These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 28448736)

  • 1. Orphan CpG islands define a novel class of highly active enhancers.
    Bell JSK; Vertino PM
    Epigenetics; 2017 Jun; 12(6):449-464. PubMed ID: 28448736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent hypermethylation of orphan CpG islands with enhancer activity in cancer.
    Bae MG; Kim JY; Choi JK
    BMC Med Genomics; 2016 Aug; 9 Suppl 1(Suppl 1):38. PubMed ID: 27534853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The recently identified modifier of murine metastable epialleles, Rearranged L-Myc Fusion, is involved in maintaining epigenetic marks at CpG island shores and enhancers.
    Harten SK; Oey H; Bourke LM; Bharti V; Isbel L; Daxinger L; Faou P; Robertson N; Matthews JM; Whitelaw E
    BMC Biol; 2015 Mar; 13():21. PubMed ID: 25857663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intragenic CpG islands play important roles in bivalent chromatin assembly of developmental genes.
    Lee SM; Lee J; Noh KM; Choi WY; Jeon S; Oh GT; Kim-Ha J; Jin Y; Cho SW; Kim YJ
    Proc Natl Acad Sci U S A; 2017 Mar; 114(10):E1885-E1894. PubMed ID: 28223506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orphan CpG islands amplify poised enhancer regulatory activity and determine target gene responsiveness.
    Pachano T; Sánchez-Gaya V; Ealo T; Mariner-Faulí M; Bleckwehl T; Asenjo HG; Respuela P; Cruz-Molina S; Muñoz-San Martín M; Haro E; van IJcken WFJ; Landeira D; Rada-Iglesias A
    Nat Genet; 2021 Jul; 53(7):1036-1049. PubMed ID: 34183853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence determinants, function, and evolution of CpG islands.
    Angeloni A; Bogdanovic O
    Biochem Soc Trans; 2021 Jun; 49(3):1109-1119. PubMed ID: 34156435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pervasive and CpG-dependent promoter-like characteristics of transcribed enhancers.
    Steinhaus R; Gonzalez T; Seelow D; Robinson PN
    Nucleic Acids Res; 2020 Jun; 48(10):5306-5317. PubMed ID: 32338759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of DNA methylation in directing the functional organization of the cancer epigenome.
    Lay FD; Liu Y; Kelly TK; Witt H; Farnham PJ; Jones PA; Berman BP
    Genome Res; 2015 Apr; 25(4):467-77. PubMed ID: 25747664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation regulates discrimination of enhancers from promoters through a H3K4me1-H3K4me3 seesaw mechanism.
    Sharifi-Zarchi A; Gerovska D; Adachi K; Totonchi M; Pezeshk H; Taft RJ; Schöler HR; Chitsaz H; Sadeghi M; Baharvand H; Araúzo-Bravo MJ
    BMC Genomics; 2017 Dec; 18(1):964. PubMed ID: 29233090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT5 Regulation of Sex-Dependent Hepatic CpG Methylation at Distal Regulatory Elements Mapping to Sex-Biased Genes.
    Hao P; Waxman DJ
    Mol Cell Biol; 2021 Jan; 41(2):. PubMed ID: 33199496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orphan CpG islands identify numerous conserved promoters in the mammalian genome.
    Illingworth RS; Gruenewald-Schneider U; Webb S; Kerr AR; James KD; Turner DJ; Smith C; Harrison DJ; Andrews R; Bird AP
    PLoS Genet; 2010 Sep; 6(9):e1001134. PubMed ID: 20885785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic profiling of DNA methyltransferases reveals a role for DNMT3B in genic methylation.
    Baubec T; Colombo DF; Wirbelauer C; Schmidt J; Burger L; Krebs AR; Akalin A; Schübeler D
    Nature; 2015 Apr; 520(7546):243-7. PubMed ID: 25607372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CpG island-mediated global gene regulatory modes in mouse embryonic stem cells.
    Beck S; Lee BK; Rhee C; Song J; Woo AJ; Kim J
    Nat Commun; 2014 Nov; 5():5490. PubMed ID: 25405324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An annotated list of bivalent chromatin regions in human ES cells: a new tool for cancer epigenetic research.
    Court F; Arnaud P
    Oncotarget; 2017 Jan; 8(3):4110-4124. PubMed ID: 27926531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GC skew defines distinct RNA polymerase pause sites in CpG island promoters.
    Kellner WA; Bell JS; Vertino PM
    Genome Res; 2015 Nov; 25(11):1600-9. PubMed ID: 26275623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lineage-specific DNA methylation in T cells correlates with histone methylation and enhancer activity.
    Schmidl C; Klug M; Boeld TJ; Andreesen R; Hoffmann P; Edinger M; Rehli M
    Genome Res; 2009 Jul; 19(7):1165-74. PubMed ID: 19494038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pan-cancer analysis of CpG Island gene regulation reveals extensive plasticity within Polycomb target genes.
    Zheng Y; Huang G; Silva TC; Yang Q; Jiang YY; Koeffler HP; Lin DC; Berman BP
    Nat Commun; 2021 Apr; 12(1):2485. PubMed ID: 33931649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-genome bisulfite sequencing maps from multiple human tissues reveal novel CpG islands associated with tissue-specific regulation.
    Mendizabal I; Yi SV
    Hum Mol Genet; 2016 Jan; 25(1):69-82. PubMed ID: 26512062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells.
    Zhao MT; Shao NY; Hu S; Ma N; Srinivasan R; Jahanbani F; Lee J; Zhang SL; Snyder MP; Wu JC
    Circ Res; 2017 Nov; 121(11):1237-1250. PubMed ID: 29030344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CpG binding protein (CFP1) occupies open chromatin regions of active genes, including enhancers and non-CpG islands.
    van de Lagemaat LN; Flenley M; Lynch MD; Garrick D; Tomlinson SR; Kranc KR; Vernimmen D
    Epigenetics Chromatin; 2018 Oct; 11(1):59. PubMed ID: 30292235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.